The aims of the Precision and Future Medicine (P&FM) are to convey new messages regarding general medicine to the global community and to encourage and expedite the publication of medical discoveries, innovations, and new concepts in medicine for our beneficiaries. Thus, the journal is distinct from ordinary medical journals as it accepts and publishes new and innovative diagnostic and therapeutic information with greater priority over conventional clinical trial results. We have a particular interest in new discoveries that are readily applicable to patients (such as omics-driven patient care), translational drug discoveries (including preclinical experiments or stem cells), novel diagnostic methods, and medical devices for healthcare in the field of medicine (i.e. cancer, neurologic disease, cardiovascular disease, hereditary disease, infectious disease, degenerative disease, geriatric medicine, gastroenterology, endocrinology, etc.)

The journal will consider submissions in areas including, but not limited to, the following: clinical papers, translational, genomic, therapeutic, and biotechnological research papers. The journal also welcomes laboratory and animal studies on new drugs and novel medical devices and those that elucidate targetable mechanisms of human diseases.

These aims and scope will be executed through various types of publications—Original Articles, Reviews, Case Reports, Opinions, and Letters to the Editor. The P&FM will be published four times per year: March 31^st, June 30^th, September 30^th, and December 31^st.